Connecting with our customers!
In the last few months we have organized several of our own digital events to stay connected with our customers given the impossibility of meeting in person.
We are very satisfied with the level of participation obtained in our pig and bovine webinars. In total, we have reached 839 people from Spain, Portugal and Latin America, and have been connected live to as much as 52% of the audience. Furthermore, the value of accessing content on a deferred basis, viewing after the event, exceed the number of registrations, which confirms the interest and relevance of speakers’ content.
Among the evaluations received by attendees, the high level satisfaction in regard to the quality of content, the high degree of interactivity of the platform and technical support, the specialization of speakers on the topics broached and their willingness to take part again in this kind of event with us are all worthy of mention.
You may also be interested in
30 January, 2025
Syvac® EH Marker, the first and only DIVA vaccine against EHD, is now authorized in Belgium
Syva is pleased to announce that the FAMHP/FAGG has granted emergency use authorization for its marker (DIVA) vaccine against EHD in accordance with Article 110(2) of Regulation (EU) 2019/6 for use in cattle and deer.
24 January, 2025
Call for the 28th edition of the Syva Award International for the best doctoral thesis in Animal Health
We are pleased to remind you that the call for applications for the 28th Syva Award International is open until 18 February 2025. We also remind you that for two years now, the Syva Award International is no longer limited to Spanish candidates, but invites all doctoral students of any nationality who have submitted their thesis in animal health...
22 January, 2025
Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).
On 15 January 2025, the Committee for Medicinal Products for Veterinary Use (CVMP) issued a positive opinion recommending the granting of a marketing authorization for Syvazul BTV 3 vaccine. This step forward marks an important milestone in the fight against Bluetongue, and Syva is proud to be at the forefront of this innovation.
Media tool kit
We provide users, particularly journalists and the press, with a series of graphic documents, photographs and videos. We offer the free use of these documents under certain conditions
Journalist and Press Contact
Are you a journalist, part of the press or the media? Do you want to get information on our activities, validate your sources in a professional manner, obtain validated photographic material or request an interview?
Next Events
